TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Pharmasset, Inc. Investor Files Lawsuit To Stop The Takeover Bid By Gilead Sciences

  • If you purchased shares of Pharmasset, Inc. (NASDAQ:VRUS) prior to the announcement and currently hold those shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

San Diego, Nov. 29, 2011 (Shareholders Foundation) -- An investor in NASDAQ:VRUS shares filed a lawsuit in State Court against directors of Pharmasset, Inc in effort to block the proposed acquisition of Pharmasset, Inc by Gilead Sciences, Inc for $137 per share. According to the complaint the plaintiff alleges that the defendants breached their fiduciary duties owed to Pharmasset, In...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: